Direkt zum Inhalt
Merck

An adaptive role of TNFα in the regulation of striatal synapses.

The Journal of neuroscience : the official journal of the Society for Neuroscience (2014-05-03)
Gil M Lewitus, Horia Pribiag, Rachna Duseja, Michel St-Hilaire, David Stellwagen
ZUSAMMENFASSUNG

Elevation of inflammatory cytokines in the striatum precedes symptoms in a number of motor dysfunctions, but it is unclear whether this is part of the disease process or an adaptive response to the pathology. In pyramidal cells, TNFα drives the insertion of AMPA-type glutamate receptors into synapses, and contributes to the homeostatic regulation of circuit activity in the developing neocortex. Here we demonstrate that in the mouse dorsolateral striatum, TNFα drives the internalization of AMPARs and reduces corticostriatal synaptic strength, dephosphorylates DARPP-32 and GluA1, and results in a preferential removal of Ca(2+)-permeable AMPARs. Striatal TNFα signaling appears to be adaptive in nature, as TNFα is upregulated in response to the prolonged blockade of D2 dopamine receptors and is necessary to reduce the expression of extrapyramidal symptoms induced by chronic haloperidol treatment. These data indicate that TNFα is a regulator of glutamatergic synaptic strength in the adult striatum in a manner distinct from its regulation of synapses on pyramidal cells and mediates an adaptive response during pathological conditions.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Anti-Glyceraldehyd-3-phosphat-dehydrogenase-Antikörper, Klon 6C5, clone 6C5, Chemicon®, from mouse
Sigma-Aldrich
Haloperidol, powder
Sigma-Aldrich
Anti-Glutamatrezeptor-1-Antikörper, from rabbit, purified by affinity chromatography
Supelco
Haloperidol solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
USP
Haloperidol, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Anti-phospho-GluR1(Ser831)-Antikörper, Klon N453, Kaninchen, monoklonal, culture supernatant, clone N453, Upstate®
Haloperidol, European Pharmacopoeia (EP) Reference Standard
Haloperidol für die Systemeignung, European Pharmacopoeia (EP) Reference Standard
Haloperidol für die Peakidentifizierung, European Pharmacopoeia (EP) Reference Standard